Carrier testing is a type of genetic testing used to determine if a person is a carrier for a specific autosomal recessive disorder. An autosomal recessive disorder means two copies of an abnormal gene must be present in order for the disease or trait to develop. This type of testing is used most often by those considering becoming pregnant. Carrier testing assists in the evaluation of risk of a child inheriting certain genetic disorders. Our cutting edge technological platform for carrier test provides critical genomic information for parents and physicians to make crucial decisions regarding their personalized healthcare and family plan.
The Genetic Disorders being tested at Elite are the following.
- Cystic Fibrosis
- Duchenne/Becker Muscular Dystrophy
- Spinal Muscular Atrophy
- Beta Hemoglobinopathies
- Bloom Syndrome
- Canavan Disease
- Familial Dysautonomia
- Fanconi Anaemia
- Gaucher Disease
- Mucolipidosis IV
- Niemann-Pick Disease
- Tay-Sachs Disease
Elite Medical offers pharmacogenetics testing to provide insight as to a patient’s likeliness to experience an adverse reaction or a non-response to a drug. Elite’s pharmacogenetics testing includes 25 genes targeting more than 70 genetic variants that are especially dedicated to drug therapy in pain management, psychological disorders and cardiovascular diseases. This testing utilizes one of the most advanced instruments designed for gene detection.
With its optimized automation and high-throughput capability, Elite Medical is able to offer an advanced pharmacogenetics testing highlighting every individual’s specific genetic makeup that predetermines drug metabolism or lack thereof. This insight not only helps healthcare providers determine which class of medication to prescribe but also identifies any adverse reactions to medication classes that could possibly occur.
Cancer Genetics is a study of heritable gene variants that cause or confer altered risk of tumor or hematological malignancy. Genetic changes that promote cancer can be passed on from generation to generation if the changes are present in constitutional DNA. Cancer causing genetic changes can also be acquired during one’s lifetime, as the result of random errors of cell divisions or exposure to carcinogenic chemicals and radiations that damage DNA.
Cancer genetic testing reveals a genetic predisposition to specific genetic variants that are often inherited from a parent. These variations can be harmful and may increase a person’s chance or risk of developing a disease or cancer.